James M Mock Moderna, Inc. (MRNA) insider trading activity

James M Mock is Chief Financial Officer of Moderna, Inc.. Currently has a direct ownership of 11,066 shares of MRNA, which is worth approximately $438,102. The most recent transaction as insider was on Nov 29, 2024, when has been sold 1,420 shares (Common Stock) at a price of $42.79 per share, resulting in proceeds of $60,761. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.1K

26.22% 3M change

274.86% 12M change

Total Value Held $438,102

James M Mock Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 29 2024	SELL Open market or private sale	$60,761 $42.79 p/Share	1,420 Reduced 11.37%	11,066 Common Stock
Nov 27 2024	BUY Exercise of conversion of derivative security	-	2,981 Added 19.27%	12,486 Common Stock
Oct 07 2024	SELL Open market or private sale	$42,985 $60.12 p/Share	715 Reduced 7.0%	9,505 Common Stock
Oct 04 2024	BUY Exercise of conversion of derivative security	-	1,453 Added 12.45%	10,220 Common Stock
Aug 29 2024	SELL Open market or private sale	$12,640 $78.03 p/Share	162 Reduced 1.81%	8,767 Common Stock
Aug 28 2024	SELL Open market or private sale	$104,874 $79.39 p/Share	1,321 Reduced 13.32%	8,600 Common Stock
Aug 28 2024	BUY Exercise of conversion of derivative security	-	329 Added 3.55%	8,929 Common Stock
Aug 27 2024	BUY Exercise of conversion of derivative security	-	2,652 Added 21.09%	9,921 Common Stock
Jul 08 2024	SELL Open market or private sale	$81,467 $118.24 p/Share	689 Reduced 8.66%	7,269 Common Stock
Jul 05 2024	BUY Exercise of conversion of derivative security	-	1,452 Added 15.43%	7,958 Common Stock
Jun 03 2024	SELL Open market or private sale	$97,237 $140.72 p/Share	691 Reduced 9.6%	6,506 Common Stock
May 31 2024	BUY Exercise of conversion of derivative security	-	1,326 Added 15.56%	7,197 Common Stock
May 29 2024	SELL Open market or private sale	$26,443 $144.5 p/Share	183 Reduced 3.02%	5,871 Common Stock
May 28 2024	SELL Open market or private sale	$105,280 $162.47 p/Share	648 Reduced 10.17%	5,726 Common Stock
May 28 2024	BUY Exercise of conversion of derivative security	-	328 Added 5.14%	6,054 Common Stock
May 24 2024	BUY Exercise of conversion of derivative security	-	1,326 Added 17.22%	6,374 Common Stock
Apr 08 2024	SELL Open market or private sale	$71,860 $101.93 p/Share	705 Reduced 12.25%	5,048 Common Stock
Apr 05 2024	BUY Exercise of conversion of derivative security	-	1,453 Added 20.16%	5,753 Common Stock
Feb 29 2024	SELL Open market or private sale	$61,186 $94.57 p/Share	647 Reduced 13.08%	4,300 Common Stock
Feb 28 2024	BUY Exercise of conversion of derivative security	-	1,315 Added 21.0%	4,947 Common Stock
Jan 08 2024	SELL Open market or private sale	$84,727 $109.75 p/Share	772 Reduced 17.53%	3,632 Common Stock
Jan 05 2024	BUY Exercise of conversion of derivative security	-	1,452 Added 24.8%	4,404 Common Stock
Oct 06 2023	SELL Open market or private sale	$292,945 $102.5 p/Share	2,858 Reduced 49.19%	2,952 Common Stock
Oct 05 2023	BUY Exercise of conversion of derivative security	-	5,810 Added 50.0%	5,810 Common Stock

Also insider at

PKI

PERKINELMER INC Healthcare

Officer

JMM

James M Mock

Chief Financial Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account